Beneficial effects of erythropoietin in preclinical models of shock and organ failure.docVIP

Available online /content/11/3/132 Commentary Beneficial effects of erythropoietin in preclinical models of shock and organ failure Christoph Thiemermann Centre Lead for Translational Medicine Therapeutics, The William Harvey Research Institute, Queen Mary - University of London, Barts and The London School of Medicine and Dentistry, Charterhouse Square, London EC1M 6BQ, UK Corresponding author: Christoph Thiemermann, c.thiemermann@qmul.ac.uk Published: 29 May 2007 Critical Care 2007, 11:132 (doi:10.1186/cc5912) This article is online at /content/11/3/132 ? 2007 BioMed Central Ltd See rela